176 studies found for:    "Idiopathic thrombocytopenic purpura"
Show Display Options
Rank Status Study
1 Completed Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura
Conditions: Idiopathic Thrombocytopenic Purpura;   Immune Thrombocytopenic Purpura
Intervention: Biological: Inactivated Trivalent Influenza vaccine
2 Completed Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Anti-D
3 Completed Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura
Condition: Idiopathic Thrombocytopenic Purpura
Intervention:
4 Completed Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Idiopathic Thrombocytopenic Purpura (ITP);   Immune Thrombocytopenic Purpura (ITP)
Intervention: Drug: rituximab
5 Completed Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Placebo;   Drug: AKR-501 Tablets
6 Completed Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Idiopathic Thrombocytopenic Purpura (ITP)
Intervention: Drug: PG2
7 Completed Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution
8 Completed Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Helicobacter Pylori Infection
Intervention: Drug: lansoprazole, clarithromycin, amoxycillin
9 Completed
Has Results
A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Chronic Idiopathic Thrombocytopenic Purpura
Intervention: Biological: Gammaplex, intravenous immunoglobulin
10 Unknown  Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
Condition: Acute Idiopathic Thrombocytopenic Purpura
Intervention:
11 Completed
Has Results
Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: SB-497115-GR 12.5mg;   Drug: SB-497115-GR 25mg;   Drug: SB-497115-GR 12.5mg matching placebo;   Drug: SB-497115-GR 50 mg
12 Terminated Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Biological: GMA161
13 Completed Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: AMG 531
14 Completed
Has Results
A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: rituximab [MabThera/Rituxan]
15 Completed Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Idiopathic Thrombocytopenic Purpura (ITP)
Intervention: Drug: IgNextGen 10%
16 Completed
Has Results
Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Eltrombopag oral tablets
17 Completed
Has Results
A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: rituximab;   Drug: Dexamethasone
18 Completed Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Intervention: Drug: rhTPO in combination with Rituximab
19 Active, not recruiting The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: Dexamethasone;   Drug: Dexamethasone and Rituximab
20 Withdrawn All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Drug: All-Trans Retinoid Acid(ATRA);   Drug: Dexamethasone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years